Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1998-2-4
pubmed:abstractText
Insulin-like growth factor II (IGF-II) is highly expressed during hepatocarcinogenesis (P. Schirmacher et al., Cancer Res., 52: 2549-2556, 1992; B. C. Park et al., J. Hepatol., 22: 286-294, 1995). However, the mechanism of its enhanced expression is largely unknown. In this study, we show that IGF-II mRNA levels are increased within six h of exposing human hepatoma cell cultures to hypoxia, suggesting that hypoxia may be a strong stimulus for the induction of IGF-II expression in the process of hepatocarcinogenesis. This finding and the fact that hepatocellular carcinoma (HCC) is a typical hypervascular tumor (M. Mise et al., Hepatology, 23: 455-464, 1996) imply that IGF-II may play an important role in the development of neovascularization of HCC. Here we demonstrate that IGF-II substantially increases vascular endothelial growth factor (VEGF) mRNA and protein levels in a time-dependent manner in human hepatoma cells. The induction of VEGF by IGF-II was additively increased by hypoxia. Moreover, the direct angiogenic activity of IGF-II was observed in the quantitative chick chorioallantoic membrane assay (M. Nguyen et al., Microvasc. Res., 47: 31-40, 1994). These data suggest that IGF-II may be a hypoxia-inducible angiogenic factor in HCC.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0008-5472
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
58
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
348-51
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9443416-Animals, pubmed-meshheading:9443416-Blotting, Northern, pubmed-meshheading:9443416-Carcinoma, Hepatocellular, pubmed-meshheading:9443416-Cell Hypoxia, pubmed-meshheading:9443416-Chick Embryo, pubmed-meshheading:9443416-Chorion, pubmed-meshheading:9443416-Endothelial Growth Factors, pubmed-meshheading:9443416-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:9443416-Humans, pubmed-meshheading:9443416-Immunoenzyme Techniques, pubmed-meshheading:9443416-Insulin-Like Growth Factor II, pubmed-meshheading:9443416-Liver, pubmed-meshheading:9443416-Liver Cirrhosis, pubmed-meshheading:9443416-Liver Neoplasms, pubmed-meshheading:9443416-Lymphokines, pubmed-meshheading:9443416-Neovascularization, Pathologic, pubmed-meshheading:9443416-RNA, Messenger, pubmed-meshheading:9443416-Recombinant Proteins, pubmed-meshheading:9443416-Tumor Cells, Cultured, pubmed-meshheading:9443416-Vascular Endothelial Growth Factor A, pubmed-meshheading:9443416-Vascular Endothelial Growth Factors
pubmed:year
1998
pubmed:articleTitle
Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma.
pubmed:affiliation
Department of Molecular Biology, Pusan National University, Korea. kimkw@hyowon.cc.pusan.ac.kr
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't